Literature DB >> 23337549

FIP1L1-PDGFRα-positive hypereosinophilic syndrome in childhood: a case report and review of literature.

Piero Farruggia1, Emilia Giugliano, Delia Russo, Angela Trizzino, Roberta Lorenzatti, Alessandra Santoro, Paolo D'Angelo.   

Abstract

Hypereosinophilic syndromes in children are rare disorders traditionally characterized by an eosinophil count exceeding 1,500/mm³ on at least 2 occasions or evidence of tissue eosinophilia associated with symptoms and marked blood eosinophilia, lacking any secondary cause (such as infections, allergic disease, chemical-induced eosinophilia, hypoadrenalism, cancer). Until now there have only been 3 reported cases of pediatric FIP1L1-PDGFRα-positive hypereosinophilic syndromes. We describe a fourth patient, a white 14-year-old boy, the third treated with imatinib.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23337549     DOI: 10.1097/MPH.0b013e31827e6386

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Hypereosinophilia in Children and Adults: A Retrospective Comparison.

Authors:  Kelli W Williams; JeanAnne Ware; Annalise Abiodun; Nicole C Holland-Thomas; Paneez Khoury; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2016-04-27

2.  Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.

Authors:  Sofia Bota; Pedro Alves; Claudia Constantino; Raquel Maia
Journal:  BMJ Case Rep       Date:  2019-04-29

3.  Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia.

Authors:  Juhi Jain; Elizabeth P Weinzierl; Debra Saxe; John Bergsagel; Jason Gotlib; Andreas Reiter; Sunil S Raikar
Journal:  Hemasphere       Date:  2020-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.